Siemens Healthcare Diagnostics, Tarrytown, NY, introduces the LOCI® CA 19-9™ assay for use on Dimension Vista® Systems.
The release of this assay further expands the oncology menu for the Dimension Vista 1500 and Vista 500 systems, providing a core oncology menu to laboratories.
LOCI technology comprises a homogeneous, sandwich chemiluminescent immunoassay technology.
The oncology assays provide outstanding performance while consolidating even more tumor marker testing on a single platform. Features include:
- Excellent precision for consistency in results reporting and accurate patient monitoring
- Broad dynamic assay ranges to limit need for sample dilutions
- Rapid assay kinetics to reduce TAT and provide better service levels to physicians and cancer patients anxiously awaiting results.
- Minimal sample volumes to eliminate sample splitting and simplify workflow.
Click here to learn more.
[Source: Siemens Healthcare Diagnostics]
